Clovis Oncology Announces 2016 Operating Results

Go back to Clovis Oncology Announces 2016 Operating Results

Clovis Oncology (CLVS) Misses Q4 EPS by 18c

February 22, 2017 4:07 PM EST

Clovis Oncology (NASDAQ: CLVS) reported Q4 EPS of ($1.83), $0.18 worse than the analyst estimate of ($1.65).

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.

... More